Niowave is a domestic supplier of medical and industrial radioisotopes from uranium and radium. Isotope inventories available for purchase include alpha, beta, and gamma sources.

The system uses a superconducting linac instead of a nuclear reactor which eliminates the need for a nuclear reactor and weapons-grade uranium (HEU).

Isotope production and distribution utilize existing radiopharmaceutical supply chain and FDA approval processes.